Dermata Therapeutics, Inc. (DRMA)

Dermata Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3.16	7.44	6.24	10.8	0.53
Cash & Short-Term Investments	3.16	7.44	6.24	10.8	0.53
Cash Growth	-57.49%	19.18%	-42.20%	1935.97%	-73.37%
Other Receivables	-	-	0.01	-	-
Receivables	-	-	0.01	-	-
Prepaid Expenses	0.36	0.45	0.6	0.77	0.08
Other Current Assets	0.01	0.09	0.09	0.06	-
Total Current Assets	3.53	7.98	6.94	11.62	0.61
Total Assets	3.53	7.98	6.94	11.62	0.61
Accounts Payable	0.81	0.87	0.5	0.52	0.1
Accrued Expenses	1.16	0.76	0.43	1	0.13
Short-Term Debt	-	-	-	-	2.99
Current Portion of Long-Term Debt	-	-	-	-	0.56
Total Current Liabilities	1.97	1.62	0.92	1.52	3.78
Total Liabilities	1.97	1.62	0.92	1.52	3.78
Common Stock	0	0	0	0	2.35
Additional Paid-In Capital	67.24	59.74	51.61	46.09	-
Retained Earnings	-65.68	-53.39	-45.59	-35.98	-28.08
Total Common Equity	1.56	6.36	6.02	10.11	-25.73
Shareholders' Equity	1.56	6.36	6.02	10.11	-3.18
Total Liabilities & Equity	3.53	7.98	6.94	11.62	0.61
Total Debt	-	-	-	-	3.55
Net Cash (Debt)	3.16	7.44	6.24	10.8	-3.02
Net Cash Growth	-57.49%	19.18%	-42.20%	-	-
Net Cash Per Share	2.07	38.16	135.55	602.41	-
Filing Date Shares Outstanding	5.43	0.44	0.05	0.03	46.66
Total Common Shares Outstanding	2.52	0.26	0.05	0.03	46.66
Working Capital	1.56	6.36	6.02	10.11	-3.18
Book Value Per Share	0.62	24.25	117.29	291.25	-0.55
Tangible Book Value	1.56	6.36	6.02	10.11	-25.73
Tangible Book Value Per Share	0.62	24.25	117.29	291.25	-0.55

Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q